Blaze Bioscience
Latest round
- Series B
Last raised
- Oct 2017
Total raised
- $16M
Investors
- 4
About Blaze Bioscience
Blaze Bioscience, Inc.Founded in 2010, Blaze Bioscience, Inc. is headquartered in Seattle, US, and specializes in cancer treatment solutions. Jim Olson, the founder, has a background in developing medical technologies, contributing to the firm's strategic direction.Blaze Bioscience, Inc. specializes in biotechnology solutions aimed at enhancing cancer patient outcomes through innovative diagnostic and therapeutic technologies. The company's core offering, Tumor Paint®, is a proprietary technology designed to improve the visualization and surgical removal of tumors by utilizing a molecular imaging system. This product, in conjunction with the CANVAS® imaging system, enables surgeons to detect cancerous tissues with greater sensitivity and reliability, thereby facilitating more precise surgical interventions. The primary end users of these products include hospitals, surgical centers, and oncologists in various geographic markets, including the United States and Europe, where there is a significant demand for advanced cancer detection and treatment options.Blaze Bioscience operates on a business model that involves direct sales to healthcare institutions and partnerships with surgical centers, allowing them to integrate their Tumor Paint® and CANVAS® imaging systems into clinical workflows. Revenue generation occurs through product sales, including agreements for the provision of their flagship technologies to hospitals and surgery centers. Transactions may follow a structured pricing plan encompassing one-time purchases or subscription agreements for ongoing support and updates of the imaging systems.In February 2019, Blaze Bioscience, Inc. The company plans to expand its product offerings, including the development of enhanced versions of Tumor Paint® and the CANVAS® imaging system. Additionally, Blaze Bioscience aims to enter new markets within Europe and Asia by 2025, targeting hospitals and surgical centers seeking improved cancer detection solutions.
Who invested in Blaze Bioscience
4 investors across 1 round
See all investors in Blaze Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 12, 2017
Amount
$16M
Investors
Questions about Blaze Bioscience
Who invested in Blaze Bioscience?
Blaze Bioscience has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Blaze Bioscience raised?
Blaze Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Blaze Bioscience last raise money?
Blaze Bioscience's most recent round on record is a Series B, in Oct 2017.
What does Blaze Bioscience do?
Blaze Bioscience is a biotechnology company.
Where is Blaze Bioscience headquartered?
Blaze Bioscience is headquartered in Seattle, US.
Which VCs invest in companies like Blaze Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Blaze Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Blaze Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.